LabCorp 2015 Annual Report Download - page 69

Index
Compensation Committee chair of Innovative Solutions & Support, Inc. Mr. Mittelstaedt brings to the Board experience as a recognized expert in business
strategy, corporate governance and executive compensation issues. Mr. Mittelstaedt serves as the Board’s Lead Independent Director and brings a deep
understanding of the role of the Board and its oversight of corporate governance and business strategy.
1,4 - Mr. Neupert (59) has served as a director of the Company since January 2013. Mr. Neupert was an Operating Partner at Health Evolution
Partners, a health only, middle market private equity firm, from January 2012 until June 2015. Prior to that, Mr. Neupert served as Corporate Vice President of
the Microsoft Health Solutions Group from its formation in 2005 to January 2012. Mr. Neupert served on the President’s Information Technology Advisory
Committee (PITAC), co-chairing the Health Information Technology subcommittee and helping to drive the “Revolutionizing Health Care Through
Information Technology” report, published in June 2004. Mr. Neupert served as the founding President and Chief Executive Officer of drugstore.com from
1998 to 2001 and as Chairman of the Board of Directors through September 2004. Mr. Neupert is also a director of Clinithink Ltd, Freedom Innovations LLC,
Adaptive Biotechnologies, Inc. and higi LLC. He served on the board of directors of QSI from August 2013 to January 2014. He serves as a trustee for the
Fred Hutchinson Cancer Research Center and was an active member of the Institute of Medicine’s Roundtable on Value & Science-Driven Healthcare from
2007-2011. Mr. Neupert brings to the Board experience as a recognized expert in health information technology and perspective on how to grow shareholder
value leveraging business strategies with technology. His prior experience as a public company CEO and board member of both private and public
companies brings practical insight to the Board with respect to business strategy, corporate governance and emerging trends in healthcare. Mr. Neupert’s
previous business experience also enables him to provide the Board with an understanding of businesses and services adjacent to the diagnostic testing
industry.
Ms. Parham (48) has been a director of the Company since January 8, 2016. Ms. Parham has more than 20 years of experience at such
companies as eBay, Visa Inc., Digitas, Inc. (now DigitasLBi) and Citibank, leading end-to-end marketing efforts including brand, performance and loyalty
marketing. Ms. Parham was most recently the Chief Marketing Officer of eBay, and prior to that she served in senior marketing roles with Visa Inc. and
Digitas, a world leading marketing agency. Ms. Parham was named to the Forbes 2014 “50 Most Influential CMOs in the World” and Fast Company’s “Most
Creative People in Business 1000.” Ms. Parham has been a member of the Board of Directors of Scripps Network Interactive Inc. since May 2012, and a
member of the Drexel University Board of Trustees since May 2014. She holds double Bachelor of Science degrees in Business Administration and Design
Arts from Drexel University.
2 ,3 - Mr. Schechter (51) has served as a director of the Company since April 1, 2013. Mr. Schechter is an Executive Vice President of
Merck & Co., Inc. and has been since 2010 President of Merck’s Global Human Health Division, which includes the company’s worldwide pharmaceutical
and vaccine businesses. He is a member of Merck’s executive committee and pharmaceutical and vaccines operating committee. Prior to becoming President,
Global Human Health, Mr. Schechter served as President, Global Pharmaceutical Business from 2007 to 2010. Mr. Schechter’s extensive experience at Merck
includes global and U.S.-focused leadership roles spanning sales, marketing, and managed markets, as well as business and product development. Mr.
Schechter serves on the board of directors for the European Federation of Pharmaceutical Industries and Associations. He is a Board Member for Water.org
and an Executive Board Member for the National Alliance for Hispanic Health. Mr. Schechter brings to the Board global business acumen and general
management experience, as well as demonstrated success in leading large, innovation-focused organizations. Mr. Schechter’s deep knowledge of the
pharmaceutical and healthcare industries and extensive experience collaborating with many of its key stakeholders to achieve patient-focused outcomes
brings practical insight to the Board with respect to business strategies to service the changing healthcare environment.
.1,3 - Dr. Williams, M.D. (66) has served as a director of the Company since May 16, 2007. Dr. Williams is President of The J. David
Gladstone Institutes and Professor of Medicine at the University of California San Francisco. Prior to this appointment, Dr. Williams served Duke University
between 2001 and 2010 as Dean of the School of Medicine, Senior Vice Chancellor, Senior Advisor for International Strategy, and founding Dean of the
Duke-NUS Graduate Medical School Singapore. He has served previously as President of the Association of University Cardiologists, Chairman of the
Research Committee of the American Heart Association, on the editorial boards of leading biomedical journals, on the Advisory Committee to the Director of
the National Institutes of Health and on the Board of External Advisors of the National Heart, Lung and Blood Institute. Dr. Williams was a director of
Bristol-Meyers Squibb Company from 2006 until May 2013 and has been a director of Amgen since October 2014. Dr. Williams is a member of the National
Academy of Medicine, and a Fellow of the American Association for the Advancement of Science. His experience as a physician, biomedical scientist, and
executive leader brings important perspective to his service to the Company as a director.
Committees:
1 Audit
2 Compensation
3 Quality and Compliance
69